1007-3418
2013 Issue 5
Comprehensive prevention and treatment of recurrence for hepatocellular carcinoma after hepatectomy
XIA Yong;SHEN Feng
XIA Yong;SHEN Feng
..............page:326-328
..............page:323,344,390,396
..............page:321-323
Combined modality therapy for recurrent hepatocellular carcinoma following liver transplantation
WANG Zheng;ZHOU Jian
WANG Zheng;ZHOU Jian
..............page:324-325
Liver histopathological features influencing HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B responding to Peg-IFN treatment
yan hua dong ; jiang fan rong ; zhu cheng liang ; gao guo sheng ; weng peng jian ; hu ai rong ; xu chang feng ; hu yao ren ; sheng ji fang
yan hua dong ; jiang fan rong ; zhu cheng liang ; gao guo sheng ; weng peng jian ; hu ai rong ; xu chang feng ; hu yao ren ; sheng ji fang
..............page:340-344
Efficacy of combination therapy with pegylated-interferon alfa-2a plus ribavirin in autoantibody-positive chronic hepatitis C patients
li ya zuo ; yang yan jia ; yang mei ; chen li yu ; lu jia zuo ; ma yuan ji ; liu kai ; lei xue zhong ; tang hong
li ya zuo ; yang yan jia ; yang mei ; chen li yu ; lu jia zuo ; ma yuan ji ; liu kai ; lei xue zhong ; tang hong
..............page:345-347
Quantifiable changes in HBeAg expression predict therapeutic efficacy of peg-interferon alfa-2a in patients with HBeAg-positive chronic hepatitis B
JI Yong-jian;LI Fei-fei;REN Wan-hua;ZHU Yu-hua;QIN Cheng-yong
JI Yong-jian;LI Fei-fei;REN Wan-hua;ZHU Yu-hua;QIN Cheng-yong
..............page:335-339
Role of anti-viral therapy in survival and quality of life of patients with viral hepatitis-associated hepatocellular carcinoma
DONG Jing;JIANG Jia-ji
DONG Jing;JIANG Jia-ji
..............page:332-334
..............page:329-331
Clinical features of patients with primary biliary cirrhosis and anti-SP100 autoantibody positivity
TANG Ying-mei;BAO Wei-min;YOU Li-ying;JIANG Hong-juan;YANG Jin-hui
TANG Ying-mei;BAO Wei-min;YOU Li-ying;JIANG Hong-juan;YANG Jin-hui
..............page:359-362
Effects of inhibited IGF-IR expression on proliferation and apoptosis of human hepatocellular carcinoma cell lines
yao ning hua ; yao deng fu ; dong zhi zhen ; yan xiao zuo ; chen jie ; yao min ; wang li ; yan mei juan
yao ning hua ; yao deng fu ; dong zhi zhen ; yan xiao zuo ; chen jie ; yao min ; wang li ; yan mei juan
..............page:376-380
Expression of corticotrapin-releasing hormone receptor type-1 in intrahepatic cholestatic placental tissue
LIU Zheng-feg;HE Mao-mao;ZHOU Fan;GAO Bing-xin;WANG Xiao-dong
LIU Zheng-feg;HE Mao-mao;ZHOU Fan;GAO Bing-xin;WANG Xiao-dong
..............page:381-384
Curative effect of a comprehensive interventional treatment modality on hepatocellular carcinoma complicated with main branch portal vein tumor thrombosis
XU Guo-bin;XIONG Bin;LONG Qing-yun
XU Guo-bin;XIONG Bin;LONG Qing-yun
..............page:367-371
A preliminary study of the inhibitive efficacy of iodized linoleic acid and its fluorodeoxyuridine ester in hepatocellular cancer
LI Kai-chun;ZENG Xiao-ying;KUANG Chun-xiang;JIANG Yu-bo;DAI Zhao-yun
LI Kai-chun;ZENG Xiao-ying;KUANG Chun-xiang;JIANG Yu-bo;DAI Zhao-yun
..............page:372-375
Facial skin lesions in male patients with liver cirrhosis: role of serum sex hormones and correlation with impaired liver function
DU A-shuai;YANG Jing;LU Shuang;ZENG Jing-zhang
DU A-shuai;YANG Jing;LU Shuang;ZENG Jing-zhang
..............page:354-358
Differential expression of protease-activated receptor 2 in a bile duct ligation-induced rat model of liver fibrosis
LIU Ying-chun;GU Xiao-hong;ZHANG Yun-dong;CHEN Lan-bo;TANG Hou-mei
LIU Ying-chun;GU Xiao-hong;ZHANG Yun-dong;CHEN Lan-bo;TANG Hou-mei
..............page:363-366
Construction of a full-genome HCV replicon with self-cleaving double ribozyme sequences and characterization in vitro and in vivo
HE Chang-long;LIU Qing-shan;GUO Yan;ZHU Yan;MAO Qing;LAN Lin
HE Chang-long;LIU Qing-shan;GUO Yan;ZHU Yan;MAO Qing;LAN Lin
..............page:348-353
Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function,prognosis, and neuropeptide levels
ZHOU Ze-wen;ZHONG Xiao-ni;ZHOU Bao-yong;XIANG Ji-feng;WANG Run-hua;YI Jing
ZHOU Ze-wen;ZHONG Xiao-ni;ZHOU Bao-yong;XIANG Ji-feng;WANG Run-hua;YI Jing
..............page:385-388
Report of the Fourth Symposium on the Hotspots and Challenges in Research of Antiviral Therapy for Chronic Hepatitis B
HUANG Chen;YUAN Ping-ge;ZHU Hong-mei;PENG Zhi;ZHANG Da-zhi
HUANG Chen;YUAN Ping-ge;ZHU Hong-mei;PENG Zhi;ZHANG Da-zhi
..............page:394-396
Current perspectives on the research for establishing accurate and efficient mouse models of hepatitis C virus infections
XU Xue-lin;LI Hui
XU Xue-lin;LI Hui
..............page:397-400
Report of the Third Chinese National Symposium on Liver Fibrosis and Cirrhosis
MA Hong;XU Xiao-yuan
MA Hong;XU Xiao-yuan
..............page:393
A proposal for redefining and reclassifying cirrhosis
HU Dou-dou;YANG Ai-ting;WANG Tai-ling;YOU Hong;WANG Bao-en
HU Dou-dou;YANG Ai-ting;WANG Tai-ling;YOU Hong;WANG Bao-en
..............page:391-392
Congenital intrahepatic bile duct disease cystic expansion: a case report
LI Sheng;LI Wei;HE Sheng-song;WANG Jun;YANG Dong-liang
LI Sheng;LI Wei;HE Sheng-song;WANG Jun;YANG Dong-liang
..............page:389-390